3,4-Dihydroxyphenylacetic acid structure
|
Common Name | 3,4-Dihydroxyphenylacetic acid | ||
---|---|---|---|---|
CAS Number | 102-32-9 | Molecular Weight | 168.147 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | 418.4±30.0 °C at 760 mmHg | |
Molecular Formula | C8H8O4 | Melting Point | 127-130 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 221.0±21.1 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of 3,4-Dihydroxyphenylacetic acid3,4-Dihydroxybenzeneacetic acid is the main neuronal metabolite of dopamine. |
Name | (3,4-dihydroxyphenyl)acetic acid |
---|---|
Synonym | More Synonyms |
Description | 3,4-Dihydroxybenzeneacetic acid is the main neuronal metabolite of dopamine. |
---|---|
Related Catalog | |
Target |
Human Endogenous Metabolite |
In Vitro | 3,4-Dihydroxybenzeneacetic acid is the main neuronal metabolite of dopamine. Cerebrospinal fluid (CSF) 3,4-Dihydroxybenzeneacetic acid (DOPAC) is derived from intra-neuronal metabolism of cytoplasmic dopamine, and acts as a sensitive and specific biomarker of central dopamine deficiency[1]. |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 418.4±30.0 °C at 760 mmHg |
Melting Point | 127-130 °C(lit.) |
Molecular Formula | C8H8O4 |
Molecular Weight | 168.147 |
Flash Point | 221.0±21.1 °C |
Exact Mass | 168.042252 |
PSA | 77.76000 |
LogP | 0.17 |
Vapour Pressure | 0.0±1.0 mmHg at 25°C |
Index of Refraction | 1.643 |
Storage condition | −20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATAMUTATION DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xi:Irritant; |
Risk Phrases | R36/37/38 |
Safety Phrases | S26-S36 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | AH0590000 |
HS Code | 2918290000 |
Precursor 9 | |
---|---|
DownStream 9 | |
HS Code | 2918290000 |
---|---|
Summary | HS: 2918290000 other carboxylic acids with phenol function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their derivatives Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) VAT:17.0% MFN tariff:6.5% General tariff:30.0% |
Permeation of Dopamine Sulfate through the Blood-Brain Barrier.
PLoS ONE 10 , e0133904, (2015) Dopamine sulfate (DA-3- and DA-4-S) have been determined in the human brain, but it is unclear whether they are locally formed in the central nervous system (CNS), or transported into the CNS from per... |
|
Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator.
J. Pharmacol. Exp. Ther. 350(3) , 589-604, (2014) Brexpiprazole (OPC-34712, 7-{4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2(1H)-one) is a novel drug candidate in clinical development for psychiatric disorders with high affinity for ser... |
|
Neurotransmitter Systems in a Mild Blast Traumatic Brain Injury Model: Catecholamines and Serotonin.
J. Neurotrauma 32 , 1190-9, (2015) Exposure to improvised explosive devices can result in a unique form of traumatic brain injury--blast-induced traumatic brain injury (bTBI). At the mild end of the spectrum (mild bTBI [mbTBI]), there ... |
Benzeneacetic acid, 3,4-dihydroxy- |
DOPAC |
Benzeneacetic acid,3,4-dihydroxy |
3,4-dihydroxy-1-benzeneacetic acid |
3,4-dihydroxyphenylacetic acid |
(3,4-dihydroxyphenyl)-Acetic acid |
Homoprotocatechuic acid |
4-Carboxymethylpyrocatechol |
3,4-dihydroxyphenyl acetic acid |
Pyrocatechol-4-acetic Acid |
Benzeneacetic acid, 3,4-dihydroxy- (9CI) |
Catechol-4-acetic Acid |
(3,4-Dihydroxyphenyl)acetic acid |
Dihydroxyphenylacetic acid |
MFCD00004338 |
3,4-Dihydroxyphenylacetate |
4-Carboxymethylcatechol |
Dopacetic acid |
EINECS 203-024-1 |
Homoprotocatechuate |